Physician profile
Amber Davis
NPI 1366841702
$1,824.41
in general payments reported to CMS, 2019-2025
17 companies · $401 in 2025
The $401 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $162 · 2022: $161 · 2023: $565 · 2024: $535 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,501.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $665.40 | 2021-2025 | Verquvo, Belsomra |
| Novartis Pharmaceuticals Corporation | $402.59 | 2021-2025 | |
| Pfizer INC. | $259.50 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.41 | 2021-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $79.16 | 2021-2025 | Eliquis, Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $54.49 | 2025 | |
| Amgen INC. | $47.49 | 2021 | |
| Janssen Pharmaceuticals, INC | $45.72 | 2023 | Xarelto |
| Shockwave Medical, INC | $29.43 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cvrx, INC. | $22.00 | 2024 | Barostim Neo System |
| Inspire Medical Systems, INC. | $21.92 | 2025 | Inspire |
| Kestra Medical Technology Services, INC. | $20.23 | 2025 | Assure Wcd |
| Medtronic, INC. | $19.89 | 2023 | Corevalve Evolut R |
| Abiomed | $18.97 | 2024 | Impella |
| Abbott Laboratories | $15.83 | 2023 | Mitraclip |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14.66 | 2023 | Andexxa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8.72 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.